One of the main drivers for the development of chemical robots is the area of oncology, and especially controlled and targeted delivery of chemotherapeutics to tumors, along with the related diagnostics and control. We are focusing on the development of drug delivery platforms and their testing both ex-vivo using virtual organs produced by tissue engineering methods, and in-vivo.
